Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
HLR > SEC Filings for HLR > Form 8-K on 26-Jan-2004All Recent SEC Filings

Show all filings for HOLLINGER INTERNATIONAL INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for HOLLINGER INTERNATIONAL INC


26-Jan-2004

Other Events and Financial Statements & Exhibits

ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE.

The following information is being filed under "Item 5 - Other Events and Regulation FD Disclosure"

On January 23, 2004, the Company announced that the Corporate Review Committee of the Board of Directors met with outside financial and legal advisors to consider the implications of the pending tender offer for Hollinger Inc. by Press Holdings International Limited (the "PHIL Transaction") and the adoption by the Company of a shareholder rights plan (a so-called "poison pill"). The Corporate Review Committee is comprised of all directors on the Board of Directors, other than Lord Black of Crossharbour ("Lord Black"), Barbara Amiel Black and Dan Colson, all of whom have direct or indirect interest in Hollinger Inc. and therefore in the PHIL Transaction. A copy of the Press Release dated January 23, 2004 is filed as Exhibit 99.1 to this filing.

In addition, the Company announced that shortly after the Corporate Review Committee adjourned its meeting, members of the Board of Directors were notified that Hollinger Inc. and 504468 N.B. Inc, who together own a majority of the voting power of the Company's outstanding capital stock, executed a written consent purporting to amend certain provisions of the Company's by-laws, including amendments purporting to disband the Corporate Review Committee and materially alter the functioning of the Board of Directors (the "Purported Amendment"). A copy of the Purported Amendment as executed by Hollinger Inc. and 504468 N.B. Inc. is filed as Exhibit 99.2 to this filing.

On January 26, 2004, the Company announced that on January 25, 2004, the Corporate Review Committee continued its meeting of January 23, 2004 with outside financial and legal advisors to consider possible actions that the Company may take in response to the Purported Amendment, as well as the implications of the PHIL Transaction and the adoption of a shareholder rights plan. A copy of the Press Release dated January 26, 2004 is filed as Exhibit 99.3 to this filing.

As part of its meeting on January 25, 2004, the Corporate Review Committee unanimously approved a shareholder rights plan (the "Rights Agreement") for the benefit of shareholders of the Company, along with the declaration of a dividend of rights to acquire preferred stock. The Rights Agreement is attached as Exhibit 4.1 to this report, and contains a Summary of Rights to Purchase Preferred Shares annexed as Exhibit C to the Rights Agreement. For a description of the Rights Agreement and the Rights, please see the attached Summary of Rights to Purchase Preferred Shares and the attached Press Release filed as Exhibit 99.3.

Under the Rights Agreement, the dividend will be paid and the Rights issued to holders of record of the Company's Class A Common Stock and Class B Common Stock as of February 5, 2004, subject to a preliminary or final determination by a court of competent jurisdiction that the Corporate Review Committee remains, among other things, a duly authorized committee with the power to declare the dividend. Upon such ruling, the rights will automatically be issued to stockholder of record on the record date.

In addition to the unanimous approval of the Rights Agreement, the Company announced that the Corporate Review Committee unanimously approved the commencement of a lawsuit in Delaware Chancery Court, which was filed today, seeking the following relief, among other things: (1) declaratory relief regarding the invalidity of Lord Black's action taken through Hollinger Inc. to disband the Corporate Review Committee; (2) a preliminary injunction preventing Lord Black from continuing his breaches of fiduciary duties as director of the Company, and restraining him and companies controlled by him from taking any further action to consummate the PHIL Transaction; (3) a preliminary injunction against Lord Black's continued breach of the Restructuring Agreement, dated November 15, 2004; and (4) declaratory relief that if the PHIL Transaction is completed, the Class B Common Stock of the Company held by Hollinger Inc. will automatically be converted to shares of Class A Common Stock. For a description of the lawsuit and the reliefs sought, please see the attached Press Release filed as Exhibit 99.3.

Effective January 20, 2004, the Board of Direcvtors of the Company set the number of members of the Board of Directors at eleven (11).

ITEM 7. EXHIBITS.

(c) The exhibits below are filed together with this filing on Form 8-K:

Exhibit 4.1 Rights Agreement between the Company and Mellon Investor

                  Services LLC as Rights Agent, dated as of January 25, 2004,
                  which includes a form Certificate of Designation for the
                  Series Z Preferred Stock as Exhibit A, a form of Rights
                  Certificate as Exhibit B and a Summary of Rights to Purchase
                  Preferred Shares as Exhibit C.
Exhibit 99.1 Press Release dated January 23, 2004.

Exhibit 99.2 Written Consent of Stockholders dated January 23, 2004.

Exhibit 99.3 Press release dated January 26, 2004.

  Add HLR to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for HLR - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.